All News

    Dealing With the Unpredictability of Cancer

    July 8th 2025, 4:00pm

    Article

    My cancer journey taught me that nothing is certain; however, with support, humor and acceptance, we can weather the ups and downs.

    Bria-IMT Combo Shows Survival in Phase 2 Breast Cancer Trial

    July 8th 2025, 3:00pm

    Article

    In a phase 2 study, 52% of patients treated with Bria-IMT plus a checkpoint inhibitor for metastatic breast cancer were alive at one year.

    Screening, Prehab May Reduce Breast Cancer Survivorship Burden

    July 8th 2025, 1:00pm

    Article

    Prehabilitation and early screening, including BIS, can ease recovery, reduce side effects and help manage lymphedema after breast cancer treatment.

    Body Positivity After a Mastectomy: An Ongoing Quest

    July 7th 2025, 9:00pm

    Article

    It took years to understand why my mastectomy site looked different. Knowing I healed correctly for my procedure helped me accept my new normal.

    New Trials Target Brain, Bladder, Ovarian and Other Cancers

    July 7th 2025, 8:09pm

    Article

    New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with limited treatment paths.

    Addressing Feelings of Loneliness After a Cancer Diagnosis

    July 7th 2025, 8:00pm

    Video

    Hearing that you have cancer can lead to dark feelings; however, others have walked this road and come out on the other end, a cancer thriver explained.

    What You Can’t Do With Cancer: Talking About the Negatives

    July 7th 2025, 5:26pm

    Article

    I’ve survived rare blood cancer for 15 years, but the lasting side effects have taken a toll — even so, I still find purpose, joy and reasons to keep going.

    FDA Approves SIR-Spheres for Liver Cancer Treatment

    July 7th 2025, 4:19pm

    Article

    The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in the U.S. for both HCC and mCRC.

    FDA Grants Orphan Drug Status to MB-101 for Glioblastoma, Astrocytomas

    July 7th 2025, 3:05pm

    Article

    The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.

    Understanding the Risk of Overtreatment in Prostate Cancer

    July 7th 2025, 1:00pm

    Video

    Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit from intensified treatment.